Arbutus Biopharma and Genevant Sciences File Patent Infringe

Companies seek compensation for Pfizer’s and BioNTech’s unlicensed use of patented technologies in COVID-19 mRNA-LNP vaccines WARMINSTER, Pa., April 04, 2023 -- Arbutus... | April 4, 2023

Related Keywords

Canada , New Jersey , United States , Canadian , William Collier , Lisam Caperelli , Pfizer , Us District Court , Securities Exchange , Arbutus Biopharma Corporation Nasdaq , Pfizer Inc , Genevant Sciences , Biopharma Corporation , Looking Statements , Securities Act , Securities Exchange Act , Arbutu Annual Report , Arbutu Quarterly Reports , Arbutus Biopharma Corporation Stock Exchange , News , Information , Press Release , Companies , Eek , Compensation , Or , End , Unlicensed , Tse , F , Atented , Technologies , N , Vaccines , Pril , 023 Abus Ca03879j1003 ,